Q32 Bio (QTTB)
8.61
-0.19 (2.16%)
Upcoming Events
Latest Headlines
Form 4 Q32 Bio Inc. For: Oct 06 Filed by: Morrison Jodie Pope
October 14, 2026 5:30 PM - SEC Filing
Form 4 Q32 Bio Inc. For: Oct 06 Filed by: Violette Shelia M.
October 14, 2026 5:30 PM - SEC Filing
Form 4 Q32 Bio Inc. For: Oct 06 Filed by: Kalowski Lee
October 14, 2026 5:30 PM - SEC Filing
Leerink Starts Q32 Bio Inc. (QTTB) at Outperform
October 12, 2026 6:17 AM - StreetInsider
Form SCHEDULE 13G Q32 Bio Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
October 9, 2026 4:31 PM - SEC Filing
Why this analyst says selloff in this stock "is a misunderstanding"
October 5, 2026 8:00 PM - StreetInsider
Oppenheimer on Q32 Bio Inc. (QTTB): ' We view the weakness as a misunderstanding'
October 1, 2026 6:03 AM - StreetInsider
Form 8-K Q32 Bio Inc. For: Sep 30
September 30, 2026 9:20 AM - SEC Filing
Q32 Bio presents Phase 2a alopecia areata trial data at EADV 2026
September 30, 2026 9:17 AM - StreetInsider
Q32 Bio Presents Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata in a Late-Breaker at the European Academy of Dermatology and Venereology Congress 2026
September 30, 2026 9:15 AM - PR NewsWire
Clear Street Starts Q32 Bio Inc. (QTTB) at Buy
September 28, 2026 4:35 PM - StreetInsider
Jefferies Starts Q32 Bio Inc. (QTTB) at Buy
September 28, 2026 6:12 AM - StreetInsider
Q32 Bio to present bempikibart trial data at EADV congress
September 21, 2026 9:16 AM - StreetInsider
Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Co
September 21, 2026 9:15 AM - PR NewsWire
Q32 Bio (QTTB) Reiterated at Overweight by Cantor Fitzgerald
September 16, 2026 7:34 AM - StreetInsider
Form 8-K Q32 Bio Inc. For: Sep 14
September 14, 2026 7:16 AM - SEC Filing
Q32 Bio names new chief medical and chief development officers
September 14, 2026 6:59 AM - StreetInsider
Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
September 14, 2026 6:59 AM - PR NewsWire
Form 4 Q32 Bio Inc. For: Aug 25 Filed by: Violette Shelia M.
August 27, 2026 4:10 PM - SEC Filing
Form 4 Q32 Bio Inc. For: Aug 25 Filed by: Morrison Jodie Pope
August 27, 2026 4:10 PM - SEC Filing
Form 4 Q32 Bio Inc. For: Aug 25 Filed by: Kalowski Lee
August 27, 2026 4:10 PM - SEC Filing
Morgan Stanley Starts Q32 Bio Inc. (QTTB) at Overweight
August 24, 2026 4:47 AM - StreetInsider
Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Point72 Asset Management, L.P.
August 14, 2026 4:16 PM - SEC Filing
Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Sirenia Capital Management LP
August 14, 2026 8:36 AM - SEC Filing
Q32 Bio Inc. (QTTB) PT Lowered to $59 at Wells Fargo
August 6, 2026 6:38 AM - StreetInsider
Q32 Bio (QTTB) Tops Q2 EPS by 13c
August 5, 2026 7:21 AM - StreetInsider
Form 10-Q Q32 Bio Inc. For: Jun 30
August 5, 2026 7:10 AM - SEC Filing
Form 8-K Q32 Bio Inc. For: Aug 05
August 5, 2026 7:03 AM - SEC Filing
Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 5, 2026 6:59 AM - PR NewsWire
Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Opaleye Management Inc.
July 31, 2026 4:06 PM - SEC Filing
Form EFFECT Q32 Bio Inc.
July 29, 2026 6:08 AM - SEC Filing
Form 424B3 Q32 Bio Inc.
July 28, 2026 4:56 PM - SEC Filing
Q32 Bio Inc. (QTTB) PT Raised to $36 at H.C. Wainwright
July 28, 2026 6:00 AM - StreetInsider
Full Article List
